Clinical TrialsSearch results
Number of results: 66829
Completed
- A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19
- COVID-19
- Sugiyama Haruhito
- 2020-03-27
Completed
- A Multicenter, Open-label, Uncontrolled Phase II study of ONO-4538 [immune-checkpoint inhibitor] for cutaneous angiosarcoma
- Advanced or recurrent cutaneous hemangiosarcoma
- Fujisawa Yasuhiro
- 2020-04-22
Completed
- A Multicenter, Prospective, Open Label, Single-Arm Study of a Novel Pain Management Device, AT-04, in Patients with Acute Low Back Pain
- Acute Low Back Pain
- Miki Kenji
- 2020-02-13
Completed
- A Multicenter, Prospective, Randomized Controlled Trial: SMC-01: A Mobile Medical Application to Improve Self-Management of Patients with Type 2 Diabetes
- Type 2 Diabetes
- Ohnishi Yukiko
- 2020-05-17
Completed
- A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis
- Eosinophilic Esophagitis
- Hibi Kazushige
- 2020-11-04
Completed
- A Non-blinded Retrospective Biomarker add-on Study to FIGARO-DKD for Bioprofiling the Pharmacodynamic Response to Finerenone in FIGARO-DKD Subjects
- Chronic Kidney Disease /Type 2 Diabetes Mellitus
- Myoishi Masashi
- 2021-09-14
Completed
- A non-interventional, single-arm, multicentre, prospective study investigating the glycaemic control and treatment pattern associated with the use of Xultophy (IDegLira) in a real-world adult population with type 2 diabetes mellitus in Japan.(NN9068-4743)
- Type 2 Diebetes Mellitus
- Sudoh Yuki
- 2021-04-21
Completed
- A noninferiority study of NPC-25 in patients with hypozincemia
- hypozincemia
- Kitamura Motohiro
- 2021-12-25
Completed
- A novel system for designing orthosis
- Patients and healthy volunteers
- Nagura Takeo
- 2019-04-02
Completed
- A Ph2, randomized, double-blind, dose finding study to describe the immunogenicity, safety and tolerability of VN-0200 in Japanese adults aged 60-80 years
- Prevention of respiratory syncytial viral infection
- Inoguchi Akihiro
- 2022-09-08